ADENOCARCINOMA OF LUNG
Clinical trials for ADENOCARCINOMA OF LUNG explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF LUNG trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could gut bugs boost cancer drug power? new trial investigates
Disease control Recruiting nowThis study is testing whether adding a special gut bacteria supplement (called restorative microbiota therapy) to standard chemotherapy and immunotherapy drugs helps people with advanced lung cancer live longer without their cancer getting worse. About 82 participants will be ran…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Zapping tumors with electricity: new trial aims to turn immune system against lung cancer
Disease control Recruiting nowThis study is testing if a wearable device that delivers low-intensity electrical fields (TTFields) to the chest is safe and practical to use before surgery for early-stage lung cancer. Researchers want to see if this treatment can help activate the body's own immune system to at…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for Non-Smokers battling advanced lung cancer
Disease control Recruiting nowThis study is testing if adding an investigational drug called LP-300 to standard chemotherapy helps people with advanced lung adenocarcinoma who have never smoked. The goal is to see if this combination can better control the cancer and help patients live longer after their init…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Blood tests could revolutionize how doctors detect and monitor lung cancer recurrence
Diagnosis Recruiting nowThis study aims to improve lung cancer care by testing whether specific biomarkers in blood and tissue can better diagnose lung nodules, identify patients at high risk of cancer returning after surgery, and detect late recurrence. Researchers will follow 250 adults with suspiciou…
Matched conditions: ADENOCARCINOMA OF LUNG
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC